about
Neuropathic pain: a practical guide for the clinicianThe Effect of Diabetes Mellitus on Apoptosis in Hippocampus: Cellular and Molecular AspectsVitamin E (alpha-tocopherol) supplementation in diabetic rats: effects on the proximal colon.Role of oxidative stress in pathogenesis of metabolic syndromeEfficacy of treatment for hyperglycemic crisis in elderly diabetic patients in a day hospital.Prevalence of polymorphisms in OPG, RANKL and RANK as potential markers for Charcot arthropathy development.Nerve Decompression and Restless Legs Syndrome: A Retrospective Analysis.Diabetic neuropathy: diagnosis and treatment for the pain management specialist.Does intramedullary signal intensity on MRI affect the surgical outcomes of patients with ossification of posterior longitudinal ligament?Geriatric conditions develop in middle-aged adults with diabetes.Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives.A comparative profile of methanol extracts of Allium cepa and Allium sativum in diabetic neuropathy in miceThe pathogenesis and management of painful diabetic neuropathy: a review.Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.How the impact of median neuropathy on sensorimotor control capability of hands for diabetes: an achievable assessment from functional perspectives.Neurotrophic modulation of myelinated cutaneous innervation and mechanical sensory loss in diabetic miceEffects of axonal ion channel dysfunction on quality of life in type 2 diabetesInteractions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications.Diabetic cardiovascular autonomic neuropathy: clinical implications.Nerve decompression and neuropathy complications in diabetes: Are attitudes discordant with evidence?Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain.Biologic Basis of Nerve Decompression Surgery for Focal Entrapments in Diabetic Peripheral Neuropathy.Immunohistochemical study of vasoactive intestinal peptide (VIP) enteric neurons in diabetic rats supplemented with L-glutamine.Protective and therapeutic effects of swimming exercise training on diabetic peripheral neuropathy of streptozotocin-induced diabetic rats.The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic PEffect of l-glutamine on myenteric neuron and of the mucous of the ileum of diabetic rats.Unusual neurophysiological and immunological findings in myasthenia gravis: a case report.Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers.Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment.Muscle changes in patients with diabetes and chronic exertional compartment syndrome before and after treatment with fasciotomy.Supplementation with 0.1% and 2% vitamin E in diabetic rats: analysis of myenteric neurons immunostained for myosin-V and nNOS in the jejunum.Effects of L-glutamine supplementation on the myenteric neurons from the duodenum and cecum of diabetic rats.Associations of Diabetic Retinopathy with Retinal Neurodegeneration on the Background of Diabetes Mellitus. Overview of Recent Medical Studies with an Assessment of the Impact on Healthcare systems.
P2860
Q24553796-0F0DBACA-710F-4264-B82F-B1616DEADF3AQ26748541-7FA28629-EC38-41BC-BB55-16AE767E57D6Q30907834-844DBF48-6FBB-4B0A-A1A5-D02B834AEC91Q33361889-3A83CF52-3638-4F16-A694-C963D4C02EA3Q33636971-0F5F3079-EF4D-4C23-818A-8E9618EEB685Q33673526-08E7CD42-E43E-4F24-8EC3-22F9F9162569Q33875622-C52CFF8C-F7DB-48C3-B729-5FA6DD1918DAQ34066267-270DD576-8A4D-474F-BE82-5DF41F0933B3Q34356292-758FE3D3-E6BE-418D-8F45-BD9F795CD0D7Q34594507-56F1B30A-F3FB-4C31-8496-263EE10EA11EQ34733625-520F4224-A772-48B1-BDCD-34EC7BFEAE82Q35036226-F61C2A07-4092-4337-B734-2A28E8AB337DQ35064423-B4424C6F-B5E7-43FB-BCA4-4B77BFF5DDEDQ35080568-37CB7957-AF03-4A64-BE1D-561292AB6099Q35145277-E00B6F45-13C2-432F-A44E-C87AFEFDF310Q35754093-816012EE-524A-498D-8E1F-DF935A02C1C6Q36782662-4C147FCB-0A3F-4F48-AF4C-6692F156445EQ36966063-56AA96CA-9FD3-4A00-B35E-180A624C41F8Q38034808-B4785133-FB5E-406E-8ECE-B4915B4D9814Q41671720-ABEEEDE1-8983-4DEA-B82E-CED8BBB093D8Q42660985-A3A085FD-03B4-467E-8DC8-BB85FA0AF4E7Q42723940-8258A1D0-443D-4D59-96BB-2E633D334843Q43173273-A88E5DD0-B487-4475-A87E-EAB6C45C7474Q43971586-5CC00513-F506-4861-9138-861A7A6D7586Q44648415-5391489B-8CE6-44F0-B385-AA9F20B056BCQ44688481-A5E2DE73-D3F9-4F21-B47B-574F76D5AB49Q44856297-441F6AFF-27B8-48B0-BF6D-DCDBBD416380Q45040972-9BD19477-713F-4868-B364-5F35C51BA9E2Q45072634-2E52E8B4-7489-48CF-8D84-BD432E408882Q47557757-E0A13580-7AAF-4E98-98BD-BF41C014B52FQ48351342-A34CB2A8-3171-45F8-8FA1-97A2D66FAB70Q53124093-9EDB39FA-293D-4619-AE59-614A3E7E5636Q53250674-BE80CA5E-AB0F-4983-BDC5-FC22776653D9Q53693457-E8CB4856-C245-4339-9E54-DF29BA90346D
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Diabetic neuropathy: pathogenesis and therapy.
@ast
Diabetic neuropathy: pathogenesis and therapy.
@en
type
label
Diabetic neuropathy: pathogenesis and therapy.
@ast
Diabetic neuropathy: pathogenesis and therapy.
@en
prefLabel
Diabetic neuropathy: pathogenesis and therapy.
@ast
Diabetic neuropathy: pathogenesis and therapy.
@en
P1476
Diabetic neuropathy: pathogenesis and therapy.
@en
P2093
P304
P356
10.1016/S0002-9343(99)00009-1
P407
P577
1999-08-01T00:00:00Z